Furthermore, GPNMB has been identified as a ligand of CD44, a receptor for hyaluronic acid, which has been shown in GBM to contribute to proliferation, invasion and therapy resistance [22, 24, 41]. This evidence concerns the gene CD44 and glioblastoma.